| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/03/2023 | Oncocyte Corp | OCX | Grant | Common Stock, no par value | 141.1k | $0.35 | $50k | | 04/03/2023 |
| 04/03/2023 | Oncocyte Corp | OCX | Grant | Common Stock, no par value | 141.1k | $0.35 | $50k | See footnote | 04/03/2023 |
| 04/03/2023 | Oncocyte Corp | OCX | Grant | Common Stock, no par value | 141.1k | $0.35 | $50k | See footnote | 04/03/2023 |
| 12/23/2022 | Oncocyte Corp | OCX | Purchase | Common Stock, no par value | 250k | $0.35 | $87.9k | | 12/23/2022 |
| 08/22/2022 | SMITH MICRO SOFTWARE, INC. | SMSI | Purchase | Common Stock | 2.5k | $2.18 | $5.4k | | 08/17/2022 |
| 08/17/2022 | SMITH MICRO SOFTWARE, INC. | SMSI | Purchase | Common Stock | 25k | $2.35 | $58.8k | | 08/17/2022 |
| 08/17/2022 | Oncocyte Corp | OCX | Purchase | Common Stock, no par value | 7.5k | $0.90 | $6.8k | See footnote | 08/17/2022 |
| 08/17/2022 | Oncocyte Corp | OCX | Purchase | Common Stock, no par value | 7.5k | $0.90 | $6.8k | See footnote | 08/17/2022 |
| 08/17/2022 | SMITH MICRO SOFTWARE, INC. | SMSI | Purchase | Common Stock | 5k | $2.35 | $11.8k | By spouse IRA | 08/17/2022 |
| 08/17/2022 | SMITH MICRO SOFTWARE, INC. | SMSI | Purchase | Common Stock | 5k | $2.35 | $11.8k | By MJA Investment | 08/17/2022 |
| 08/17/2022 | SMITH MICRO SOFTWARE, INC. | SMSI | Purchase | Common Stock | 5k | $2.35 | $11.8k | By JBA Investment | 08/17/2022 |
| 08/16/2022 | Oncocyte Corp | OCX | Purchase | Common Stock, no par value | 115.5k | $0.97 | $112.1k | | 08/15/2022 |
| 08/15/2022 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 45k | $0.97 | $43.6k | | 08/15/2022 |
| 08/15/2022 | Oncocyte Corp | OCX | Grant | | 10k | $0.00 | $0 | | 08/15/2022 |
| 08/15/2022 | Oncocyte Corp | OCX | Purchase | Common Stock, no par value | 34.5k | $0.93 | $32.1k | | 08/15/2022 |
| 06/24/2022 | Oncocyte Corp | OCX | Exercise | Restricted Stock Units | 10k | $0.00 | $0 | | 06/24/2022 |
| 01/18/2022 | SMITH MICRO SOFTWARE, INC. | SMSI | Grant | | 25k | $0.00 | $0 | | 01/18/2022 |
| 06/24/2021 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 45k | $5.46 | $245.7k | | 06/24/2021 |
| 06/24/2021 | Oncocyte Corp | OCX | Grant | Restricted Stock Units | 10k | $0.00 | $0 | | 06/24/2021 |
| 02/16/2021 | SMITH MICRO SOFTWARE, INC. | SMSI | Grant | | 25k | $0.00 | $0 | | 02/16/2021 |
| 12/11/2020 | Oncocyte Corp | OCX | Grant | Common Stock | 9.6k | $0.00 | $0 | | 12/11/2020 |
| 08/10/2020 | SMITH MICRO SOFTWARE, INC. | SMSI | Grant | Common Stock | 2.5k | $3.94 | $9.9k | By JBA Investment | 08/10/2020 |
| 08/10/2020 | SMITH MICRO SOFTWARE, INC. | SMSI | Grant | Common Stock | 2.5k | $3.93 | $9.8k | By MJA Investment | 08/10/2020 |
| 08/10/2020 | SMITH MICRO SOFTWARE, INC. | SMSI | Grant | Common Stock | 10k | $3.95 | $39.4k | By spouse IRA | 08/10/2020 |
| 08/10/2020 | SMITH MICRO SOFTWARE, INC. | SMSI | Grant | Common Stock | 10k | $3.95 | $39.5k | | 08/10/2020 |
| 06/17/2020 | Oncocyte Corp | OCX | Grant | Option to purchase common stock | 57k | $2.38 | $135.7k | | 06/17/2020 |
| 02/11/2020 | SMITH MICRO SOFTWARE, INC. | SMSI | Grant | | 25k | $0.00 | $0 | | 02/11/2020 |
| 09/17/2019 | Oncocyte Corp | OCX | Purchase | Common Stock, no par value | 50k | $2.16 | $108.1k | | 09/17/2019 |
| 07/17/2019 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 45k | $2.12 | $95.4k | | 07/17/2019 |
| 02/12/2019 | SMITH MICRO SOFTWARE, INC. | SMSI | Grant | | 25k | $0.00 | $0 | | 02/12/2019 |
| 08/30/2018 | Oncocyte Corp | OCX | Grant | Option to Purchase Common Stock | 45k | $2.40 | $108k | | 08/30/2018 |
| 07/26/2018 | Oncocyte Corp | OCX | Purchase | Common stock purchase warrants | 52.4k | $3.00 | $157.3k | | 07/26/2018 |
| 07/26/2018 | Oncocyte Corp | OCX | Purchase | Common stock, no par value | 52.4k | $0.00 | $0 | | 07/26/2018 |
| 06/21/2018 | Asterias Biotherapeutics, Inc. | AST | Grant | Stock Options | 20k | $1.75 | $35k | | 06/21/2018 |
| 05/18/2018 | SMITH MICRO SOFTWARE, INC. | SMSI | Conversion | Common Stock | 43.9k | $1.14 | $50k | | 05/18/2018 |
|